Elevated plasma lipid hydroperoxides in patients with coronary artery disease

Area of Science:

• Biochemistry
• Cardiovascular Research
• Oxidative Stress

Background:

• The role of circulating lipid peroxides in atherosclerosis remains debated.
• Evidence for elevated plasma lipid peroxide levels in atherosclerotic patients is limited.

Purpose of the Study:

• To investigate the correlation between plasma total lipid hydroperoxide and LDL cholesterol lipid hydroperoxide.
• To quantify plasma lipid hydroperoxide levels in patients post-coronary artery bypass graft (CABG) surgery.
• To assess the pathological significance of elevated lipid hydroperoxides in atherosclerosis.

Main Methods:

• A specific assay was used to measure plasma lipid hydroperoxide levels.
• Correlation analysis was performed between total plasma lipid hydroperoxide and LDL cholesterol lipid hydroperoxide content.
• Plasma lipid hydroperoxide levels were compared between 70 patients 3 months post-CABG surgery and matched healthy controls.

Main Results:

• A strong positive correlation (r = 0.882, p < 0.001) was observed between plasma total lipid hydroperoxide and LDL cholesterol lipid hydroperoxide.
• Lipid hydroperoxides were found to be carried predominantly (89%) in LDL particles.
• Patients post-CABG surgery exhibited significantly increased plasma lipid hydroperoxide levels (4.31 +/- 0.23 nmol/ml) compared to healthy controls (2.34 +/- 0.13 nmol/ml, p < 0.0001).

Conclusions:

• Plasma lipid hydroperoxides are primarily associated with LDL cholesterol.
• Significantly elevated plasma lipid hydroperoxide levels are present in patients with atherosclerosis, specifically those who have undergone CABG surgery.
• These findings indicate a pathological role for lipid hydroperoxides in the context of atherosclerosis, despite concentrations being lower than those detected by less specific assays.